124.82
price up icon3.12%   3.78
pre-market  Vorhandelsmarkt:  124.81   -0.010   -0.01%
loading

Revvity Inc Aktie (RVTY) Neueste Nachrichten

pulisher
05:18 AM

Revvity Third Quarter 2024 Earnings: EPS Beats Expectations - Yahoo Finance

05:18 AM
pulisher
02:29 AM

Revvity Inc (RVTY) Q3 2024 Earnings Call Highlights: Strong EPS and Cash Flow Amid Market Challenges - GuruFocus.com

02:29 AM
pulisher
12:58 PM

Q3 2024 Revvity Inc Earnings Call - Mujer es Más

12:58 PM
pulisher
Nov 04, 2024

Revvity Reports Strong Q3 Growth and New Share Buyback - TipRanks

Nov 04, 2024
pulisher
Nov 04, 2024

Earnings call: Revitty reports solid Q3 with $684 million in revenue - Investing.com

Nov 04, 2024
pulisher
Nov 04, 2024

Revvity (NYSE:RVTY) Hits New 52-Week HighHere's Why - MarketBeat

Nov 04, 2024
pulisher
Nov 04, 2024

KeyBanc maintains $132 target on Revvity amid EPS guidance raise By Investing.com - Investing.com UK

Nov 04, 2024
pulisher
Nov 04, 2024

RVTY Q3 Earnings & Revenues Beat Estimates, Guidance Revised - MSN

Nov 04, 2024
pulisher
Nov 04, 2024

Revvity Inc price target raised to $134 by Evercore ISI - Investing.com India

Nov 04, 2024
pulisher
Nov 04, 2024

Revvity Inc (RVTY) Shares Up 5.6% on Nov 4 - GuruFocus.com

Nov 04, 2024
pulisher
Nov 04, 2024

Developing image-based T-cell assays for monitoring apoptosis and CAR expression - News-Medical.Net

Nov 04, 2024
pulisher
Nov 04, 2024

Revvity climbs after raising 2024 profit forecast - XM

Nov 04, 2024
pulisher
Nov 04, 2024

Here's What Key Metrics Tell Us About Revvity (RVTY) Q3 Earnings - Yahoo Finance

Nov 04, 2024
pulisher
Nov 04, 2024

Revvity Adjusts Revenue Forecast But Lifts Profit Expectations - Finimize

Nov 04, 2024
pulisher
Nov 04, 2024

Revvity cuts 2024 revenue forecast amid biotech spending slowdown - Reuters

Nov 04, 2024
pulisher
Nov 04, 2024

Revvity Inc (RVTY) Q3 2024 Earnings: Revenue Hits $684M, GAAP EPS Soars to $0.77, Surpassing Estimates - GuruFocus.com

Nov 04, 2024
pulisher
Nov 04, 2024

Revvity (RVTY) Surpasses Q3 Earnings and Revenue Estimates - Yahoo Finance

Nov 04, 2024
pulisher
Nov 04, 2024

Revvity: Q3 Earnings Snapshot - San Antonio Express-News

Nov 04, 2024
pulisher
Nov 04, 2024

Revvity Q3 24 Earnings Conference Call At 8:00 AM ET - Nasdaq

Nov 04, 2024
pulisher
Nov 04, 2024

Revvity beats Q3 expectations, raises full-year EPS outlook By Investing.com - Investing.com Australia

Nov 04, 2024
pulisher
Nov 04, 2024

Revvity earnings beat by $0.15, revenue topped estimates - Investing.com Canada

Nov 04, 2024
pulisher
Nov 04, 2024

Revvity, Inc. Q3 Profit Increases, Beats Estimates - Nasdaq

Nov 04, 2024
pulisher
Nov 04, 2024

Revvity, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 29, 2024 - Marketscreener.com

Nov 04, 2024
pulisher
Nov 04, 2024

International Assets Investment Management LLC Raises Holdings in Revvity, Inc. (NYSE:RVTY) - MarketBeat

Nov 04, 2024
pulisher
Nov 03, 2024

Coronation Fund Managers Ltd. Has $11.85 Million Stock Holdings in Revvity, Inc. (NYSE:RVTY) - MarketBeat

Nov 03, 2024
pulisher
Nov 02, 2024

Ceredex Value Advisors LLC Has $101.07 Million Stock Holdings in Revvity, Inc. (NYSE:RVTY) - MarketBeat

Nov 02, 2024
pulisher
Nov 02, 2024

Revvity to Report Q3 Earnings: What's in Store for the Stock? - MSN

Nov 02, 2024
pulisher
Nov 01, 2024

Revvity Inc. stock outperforms competitors on strong trading day - MarketWatch

Nov 01, 2024
pulisher
Nov 01, 2024

Revvity, Inc. (NYSE:RVTY) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat

Nov 01, 2024
pulisher
Oct 31, 2024

Revvity Inc. stock underperforms Thursday when compared to competitors - MarketWatch

Oct 31, 2024
pulisher
Oct 31, 2024

Assenagon Asset Management S.A. Trims Stock Holdings in Revvity, Inc. (NYSE:RVTY) - MarketBeat

Oct 31, 2024
pulisher
Oct 29, 2024

Revvity Introduces Transcribe AI: Revolutionizing Data Entry in Clinical Laboratories - Technology Networks

Oct 29, 2024
pulisher
Oct 28, 2024

Bay Colony Advisory Group Inc d b a Bay Colony Advisors Buys Shares of 7,696 Revvity, Inc. (NYSE:RVTY) - MarketBeat

Oct 28, 2024
pulisher
Oct 28, 2024

Earnings Preview: Revvity (RVTY) Q3 Earnings Expected to Decline - Yahoo Finance

Oct 28, 2024
pulisher
Oct 24, 2024

Revvity Board Declares Quarterly Dividend - 01Net

Oct 24, 2024
pulisher
Oct 24, 2024

Revvity Earnings Preview: What to Expect - MSN

Oct 24, 2024
pulisher
Oct 24, 2024

Revvity Inc. stock outperforms competitors despite losses on the day - MarketWatch

Oct 24, 2024
pulisher
Oct 24, 2024

Revvity, Inc. Declares Quarterly Dividend of $0.07 (NYSE:RVTY) - MarketBeat

Oct 24, 2024
pulisher
Oct 24, 2024

Here's Why Revvity (NYSE:RVTY) Can Manage Its Debt Responsibly - Simply Wall St

Oct 24, 2024
pulisher
Oct 24, 2024

Infectious Disease Diagnostics Market to Reach USD 43.09 Billion by 2031 | SkyQuest Technology - Benzinga

Oct 24, 2024
pulisher
Oct 24, 2024

Zacks Research Issues Negative Outlook for Revvity Earnings - MarketBeat

Oct 24, 2024
pulisher
Oct 24, 2024

Revvity Shares Decline Despite Launch of Transcribe AI Solution - MSN

Oct 24, 2024
pulisher
Oct 22, 2024

Revvity launches AI to digitize handwritten lab forms - Investing.com

Oct 22, 2024
pulisher
Oct 22, 2024

Revvity launches AI to digitize handwritten lab forms By Investing.com - Investing.com UK

Oct 22, 2024
pulisher
Oct 22, 2024

Revvity Highlights its Strong Progress on Sustainability and Workplace Culture in 2024 Impact Report - Business Wire

Oct 22, 2024
pulisher
Oct 21, 2024

CRISPR-based Gene Editing Market Report 2024-2030, - GlobeNewswire

Oct 21, 2024
pulisher
Oct 21, 2024

CRISPR-based Gene Editing Market Report 2024-2030, Featuring Revvity, Danaher, GenScript, Merck, Tocris Bioscience, OriGene Technologies, Bio-Rad Laboratories, Bio-Techne & New England Biolabs - Yahoo Finance

Oct 21, 2024
pulisher
Oct 21, 2024

Revvity Earnings Preview: What To Expect - Barchart

Oct 21, 2024
$218.80
price down icon 0.73%
diagnostics_research LH
$227.17
price up icon 0.03%
diagnostics_research WAT
$387.34
price up icon 0.03%
$153.49
price up icon 2.49%
diagnostics_research MTD
$1,364.02
price up icon 1.63%
$414.52
price down icon 0.66%
Kapitalisierung:     |  Volumen (24h):